Skip to Content

Join the 'Breast Cancer - Adjuvant' group to help and get support from people like you.

Breast Cancer - Adjuvant News

Could Grilled, Smoked Meats Lower Survival After Breast Cancer?

Posted 1 day 16 hours ago by Drugs.com

WEDNESDAY, Jan. 18, 2017 – Research has suggested that diets high in barbecued, grilled and smoked meats could increase the risk of breast cancer. Now, a new study finds these cooking methods may also lower survival after a breast cancer diagnosis. The study involved more than 1,500 women who had been diagnosed with the cancer in 1996 and 1997. The study participants were followed for nearly 20 years. Eating lots of grilled, barbecued or smoked meat before their cancer diagnosis was linked with a 23 percent increased risk of dying from any cause during the follow-up period compared with low intake, the researchers said. And continuing to eat lots of meat cooked in this fashion after breast cancer seemed to increase those odds, the findings suggested. Beef, pork and lamb, in particular, were singled out as potentially troublesome. Grilling, smoking and cooking meats at high temperatures ... Read more

Related support groups: Obesity, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

'Chemo Brain' Lasts for Months in Many Breast Cancer Survivors

Posted 9 days ago by Drugs.com

WEDNESDAY, Jan. 11, 2017 – "Chemo brain" – the mental fog common after breast cancer treatment – can persist for six months, new research shows. The finding comes from one of the largest studies to date to look at chemotherapy-related thinking problems that plague many women treated for breast cancer. Those problems can include memory lapses, attention issues and difficulty processing information. When researchers compared hundreds of U.S. women six months after chemotherapy ended with hundreds of healthy women, they found more than one-third of the chemotherapy group had a decline in thinking scores versus less than 15 percent of the others. "The bottom line is, this is a real problem, patients are having difficulties and we need to acknowledge it is one of the difficulties of treatment," said Dr. Patricia Ganz. Ganz is director of cancer prevention and control research at the ... Read more

Related support groups: Cancer, Provera, Depo-Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Femara, Lupron Depot, Breast Cancer, Metastatic, Anastrozole, Zoladex, Evista, Letrozole, Megestrol, Megace, Aromasin, Afinitor, Herceptin

Many With Breast Cancer Unnecessarily Choose Double Mastectomy: Study

Posted 22 Dec 2016 by Drugs.com

WEDNESDAY, Dec. 21, 2016 – Many women with early stage breast cancer choose to have their healthy opposite breast removed, even when there are no medical indications that such a step is necessary, a new survey finds. That's especially true when the surgeon doesn't offer a recommendation either way, the researchers said. "We are seeing that one in six breast cancer patients are choosing bilateral mastectomy when this aggressive procedure is not going to benefit them in terms of survival," said Dr. Reshma Jagsi. Jagsi, who led the study, is a professor and deputy chair of radiation oncology at the University of Michigan School of Medicine. Cancer specialists say no compelling evidence suggests a survival advantage for most patients to chose a double mastectomy. Also, the risk of getting cancer in the opposite healthy breast is low for most patients, they note. However, after actress ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Minority Women Less Likely to Get Breast Cancer Screening

Posted 16 Dec 2016 by Drugs.com

FRIDAY, Dec. 16, 2016 – Black and Hispanic women are less likely than white women to be screened for breast cancer, a large review finds. Screening rates for Asian/Pacific Islander and white women were similar, the research showed. The analysis of 39 studies including 6 million women was published Dec. 16 in the Journal of the American College of Radiology. "Not only do black and Hispanic women get screened less than white women, but disparities also persist in two age groups: women who are 40 to 65 years old, and 65 and older," study author Dr. Ahmed Ahmed said in a journal news release. "These findings are important; it's evident that more work needs to be done to ensure that all eligible women have access to this preventive screening tool," added Ahmed. He's a postdoctoral fellow researcher at the Mayo Clinic in Rochester, Minn. A great deal of effort has gone into finding racially ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Body Imaging

Angelina Jolie's Mastectomies Tied to Rise in Genetic Testing

Posted 15 Dec 2016 by Drugs.com

THURSDAY, Dec. 15, 2016 – After actress Angelina Jolie had both breasts removed because she faced a heightened risk for breast cancer, there was a spike in the number of women who were tested for the genes that raise that risk. But, there was no corresponding increase in mastectomy rates, researchers report. Jolie's 2013 announcement about her decision was delivered in an editorial in The New York Times. "That editorial was widely shared on social media, and we saw a jump in BRCA gene testing the day after the editorial," said lead researcher Sunita Desai. She is a fellow in the department of health care policy at Harvard Medical School in Boston. "In the two weeks after the editorial, we found a 64 percent jump in gene testing, compared with gene testing in the two weeks before the editorial, and a $13.5 million increase in spending on BRCA testing in this population," she said. "The ... Read more

Related support groups: Breast Cancer, Arimidex, Femara, Breast Cancer, Metastatic, Anastrozole, Letrozole, Aromasin, Breast Cancer - Adjuvant, Exemestane, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation, Testolactone, Teslac

Beating Breast Cancer But Still Paying a Price

Posted 15 Dec 2016 by Drugs.com

THURSDAY, Dec. 15, 2016 – Women who survive breast cancer often experience lingering physical and emotional symptoms that go untreated, new research suggests. Ninety-two percent of long-term breast cancer survivors report at least three untreated symptoms for which they need assistance, according to the study. The most common unmet needs are achy joints, fatigue and weight gain – each affecting about one in four survivors in the study. Survivors living with more unmet needs are also more likely to experience anxiety and depression, the study found. Although the study involved just over 100 mostly white and college-educated women at one cancer center, the findings may be important for the nation's 2.8 million breast cancer survivors, the study authors suggest. When you extrapolate these results to the larger population of survivors, "it gets a lot worse very quickly," said lead author ... Read more

Related support groups: Anxiety and Stress, Breast Cancer, Psychiatric Disorders, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Loneliness May Sabotage Breast Cancer Survival: Study

Posted 12 Dec 2016 by Drugs.com

MONDAY, Dec. 12, 2016 – Loneliness may impede long-term breast cancer survival, a new study suggests. In the years after treatment, women who don't have strong social ties are more likely to have their cancer return or die from it than women with friends and a support network, the researchers found. Reviewing data on nearly 10,000 breast cancer patients, the researchers linked isolation with a 40 percent higher risk of cancer recurrence compared to socially connected women. These solitary women also had a 60 percent increased risk of dying from breast cancer and a 70 percent increased risk of dying from any cause, the study found. The results weren't unexpected, the researchers said. "It is well established that women generally and those with breast cancer with greater social ties have a lower risk of death overall," said lead researcher Candyce Kroenke. She's with Kaiser Permanente's ... Read more

Related support groups: Depression, Anxiety, Anxiety and Stress, Breast Cancer, Breast Cancer, Metastatic, Psychiatric Disorders, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

Breast Cancer Death Rates Vary Around the World

Posted 11 Dec 2016 by Drugs.com

FRIDAY, Dec. 9, 2016 – Breast cancer death rates are falling in the United States and many other countries, but increasing in South Korea and some Latin American countries, researchers report. The investigators looked at data from 47 countries from 1987 to 2013. They found that breast cancer death rates declined in 39 of those nations due to advances in detection and treatment over the past few decades. The largest decrease was in England and Wales, with a 46 percent drop. In the United States, the breast cancer death rate fell 42 percent. It dropped from 22 deaths per 100,000 women in 1987-1989 to 14 deaths per 100,000 women in 2011-2013, the study showed. Rates declined in all age groups in the United States: by 50 percent for women under 50; by 44 percent for women between 50 and 69; and by 31 percent for women 70 or older. There were mixed findings from Latin America. For example, ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Strength Training May Prevent Side Effect of Breast Cancer Surgery

Posted 9 Dec 2016 by Drugs.com

FRIDAY, Dec. 9, 2016 – Strength training might benefit breast cancer survivors who've undergone surgery, researchers suggest. In a small study, weightlifting appeared to help prevent swelling in the arms and chest, a common side effect of breast cancer treatment. The study included 27 breast cancer survivors who did supervised moderate-intensity strength workouts twice a week. Each woman's regimen was matched to her ability. The women were checked every two weeks. Three had reductions in swelling and the rest did not develop any swelling. Many of the women also said they were better able to perform everyday tasks, such as opening jars or lifting heavy objects. "At one time, women were told they shouldn't do upper-body activities after surgery and treatment because doctors thought it could actually cause swelling to become worse," said study author Lynn Panton. She is a professor of ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Surgical Prophylaxis

Tamoxifen May Get Blamed for Unrelated Symptoms

Posted 9 Dec 2016 by Drugs.com

FRIDAY, Dec. 9, 2016 – Some high-risk women who take tamoxifen to prevent breast cancer may mistake naturally occurring nausea and vomiting for side effects of the drug and stop taking it, a new study finds. Previous research has shown that taking tamoxifen can reduce the risk of breast cancer by more than 30 percent in high-risk women, and the preventive effects last more than 20 years, the study authors said. But a study of women taking tamoxifen in the United Kingdom found that one-third didn't continue the treatment for the recommended five years. Those who experienced nausea and vomiting were more likely to stop taking the drug than those without such symptoms, the findings showed. However, women who were taking an inactive placebo and had the same symptoms were equally likely to stop. That suggests that some symptoms triggered by other causes were being mistaken for side effects ... Read more

Related support groups: Breast Cancer, Tamoxifen, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Tamoxifen Hexal, Nolvadex, Tamosin, Emblon, Soltamox, Tamone, Tamoxen, Genox, Nolvadex D, Tamofen

Could a Computer Someday Guide Breast Cancer Care?

Posted 9 Dec 2016 by Drugs.com

FRIDAY, Dec. 9, 2016 – An artificially intelligent computer system is making breast cancer treatment recommendations on a par with those of cancer doctors, a new study reports. The IBM computer system – called Watson Oncology – made treatment recommendations that jibed nine out of 10 times with those of a multidisciplinary board of doctors at a top cancer hospital in India, researchers say. In cases involving more complex cancers, however, the computer did not hit that 90 percent mark. Another version of Watson famously defeated two former winners on the game show "Jeopardy!" in 2011, winning a first-place prize of $1 million. In its oncology role, Watson digests a patient's medical history and current cancer data in under a minute. It then spends another minute reviewing all existing medical evidence regarding their particular form of cancer, said study co-author Dr. S.P. ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Breast Cancer - Male, Osteolytic Bone Metastases of Breast Cancer

New Drug Combo Shows Promise Curbing Tough-to-Treat Breast Cancer

Posted 8 Dec 2016 by Drugs.com

THURSDAY, Dec. 8, 2016 – In women with a certain form of tough-to-treat breast cancer, treatment with a combination of two drugs appeared to keep the cancer at bay longer – from about five months to 10, a new study says. The cancer is known as "advanced hormone receptor positive, HER 2 negative" breast cancer. Women with these tumors are often given drugs called aromatase inhibitors, which work by reducing estrogen in the body and slowing the growth of the cancer. However, patients commonly develop resistance to aromatase inhibitor drugs, and they stop working. This is also known as endocrine therapy resistance. The new research may offer these patients some hope, researchers said. "Our study has shown that combining a newer medicine called everolimus [Afinitor] with a more established medicine, fulvestrant [Faslodex], has demonstrated benefit in aromatase inhibitor resistant breast ... Read more

Related support groups: Breast Cancer, Estradiol, Premarin, Ethinyl Estradiol, Estrace, Arimidex, Femara, Vagifem, Estrace Vaginal Cream, Vivelle, Breast Cancer, Metastatic, Anastrozole, Climara, Letrozole, Estring, Vivelle-Dot, Premarin Vaginal, Aromasin, Estradiol Patch, Afinitor

Breast Cancer Cells May Change When They Spread to Brain: Study

Posted 7 Dec 2016 by Drugs.com

WEDNESDAY, Dec. 7, 2016 – When breast cancer spreads to the brain, important molecular changes may occur in the cancer, a small study found. The discovery of these changes could lead to improved diagnosis and treatment, the researchers said. About 20 percent of breast cancers are a type known as HER2-positive, which typically respond to targeted therapies. However, HER2-negative breast cancer that has spread to the brain doesn't respond to the same therapies. In this study, researchers analyzed tumors from 20 patients in the United States and Ireland. They found that primary breast cancer identified as HER2-negative switched to HER2-positive when it spread to the brain. The findings show that treatments should target not only the original breast cancer, but also brain tumors, said study author Adrian Lee, director of the Institute for Precision Medicine, part of the University of ... Read more

Related support groups: Breast Cancer, Estradiol, Premarin, Ethinyl Estradiol, Estrace, Arimidex, Femara, Vagifem, Estrace Vaginal Cream, Vivelle, Breast Cancer, Metastatic, Anastrozole, Climara, Letrozole, Estring, Premarin Vaginal, Vivelle-Dot, Aromasin, Estradiol Patch, Herceptin

Taking Breast Cancer Prevention Drug Beyond 5 Years May Not Raise Survival

Posted 7 Dec 2016 by Drugs.com

WEDNESDAY, Dec. 7, 2016 – Many breast cancer survivors take anti-estrogen drugs for at least five years to help lessen their risk of recurrence. Now, new research suggests that taking such a drug for an even longer period might not confer any added benefit – at least in terms of survival. The study of thousands of older breast cancer survivors found that taking the aromatase inhibitor drug letrozole (Femara) for more than the recommended five years did not help them live longer. However, other benefits were noted, so the decision to extend use of drugs like these is one best made on a case-by-case basis, cancer specialists said. One oncologist who reviewed the new findings said the study has been "eagerly awaited," since many breast cancer survivors are counseled to take an aromatase inhibitor. "For now, this trial reinforces the need to listen to our patients and weigh out the risk ... Read more

Related support groups: Breast Cancer, Arimidex, Femara, Breast Cancer, Metastatic, Anastrozole, Letrozole, Aromasin, Breast Cancer - Adjuvant, Exemestane, Breast Cancer, Prevention, Breast Cancer - Palliative, Breast Cancer - Male, Osteolytic Bone Metastases of Breast Cancer, Teslac, Testolactone

Never Too Old for a Mammogram?

Posted 28 Nov 2016 by Drugs.com

MONDAY, Nov. 28, 2016 – Women who think they're too old to worry about mammograms may want to reconsider the age at which their breast cancer screening years are behind them, a new study suggests. Based on an analysis of nearly 7 million mammograms over a seven-year period, "the benefit continues with increasing age up until 90," said study author Dr. Cindy Lee. She is an assistant professor in residence at the University of California, San Francisco. The question of when to stop having mammograms has been widely debated. In 2009, the U.S. Preventive Services Task Force issued new guidelines, saying there wasn't enough evidence to assess the balance of benefits and harms of screening mammography in women aged 75 and older. Lee and her colleagues looked at patient age, mammogram results, recall rates for more testing, biopsy referrals and biopsy results. The investigators also looked at ... Read more

Related support groups: Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Body Imaging

Page 1 2 3 4 5 6 7 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer

Related Drug Support Groups

Lupron, tamoxifen, Femara, letrozole, Herceptin, Taxol, paclitaxel, leuprolide, epirubicin, view more... trastuzumab, Tamoxifen Hexal, Nolvadex, Tamoxen, Pharmorubicin RDF, Pharmorubicin PFS, Tamosin, Genox, Tamone, Onxol, Ellence, Soltamox, Emblon, Tamofen, Nolvadex D